COMMUNIQUÉS West-GlobeNewswire
-
Capra Biosciences Launches Bioproduced Salicylic Acid for Personal Care at NYSCC Suppliers’ Day
19/05/2026 -
Enspire Dental Launches New Emergency Care Initiative to Assist Ann Arbor Families During Dental Crises
19/05/2026 -
NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration
19/05/2026 -
Resmed and ŌURA Partner to Expand Access to Sleep Health Education and Care
19/05/2026 -
Atos Selected by Viasat to Modernize Global Digital Workplace Operations
19/05/2026 -
dacadoo and Bradesco Vida e Previdência Partner to Bring Digital Health Engagement to Millions in Brazil
19/05/2026 -
SafeSpace Global Corp. (OTCID: SSGC) to Present at the Sidoti Micro-Cap Virtual Conference on May 21st
19/05/2026 -
BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution)
19/05/2026 -
ENvue Medical to Showcase ENvue™ Navigation Platform at AACN NTI 2026
19/05/2026 -
Edesa Biotech to Present New Data on Paridiprubart in Acute Kidney Injury at European Nephrology Conference
19/05/2026 -
NeOnc Technologies Gains Growing Institutional Support Ahead of Key Brain Cancer Clinical Milestones
19/05/2026 -
Joshua Fritzler Named President of Olympia and Wesley Pharmaceuticals
19/05/2026 -
Commure Raises $70M at $7B Valuation to Transform Healthcare Operations Using AI
19/05/2026 -
Merit Medical Shareholders Elect Scott R. Ward to Board of Directors
19/05/2026 -
Dyadic Applied BioSolutions Announces Participation in Sidoti Virtual Investor Conference
19/05/2026 -
Nord Pilates Surpasses 1,300 Customer Reviews as Women Praise Personalized Pilates Plans and Low-Impact Home Workouts
19/05/2026 -
Curia Completes Upgrade of API Aseptic Suites in Valladolid, Spain
19/05/2026 -
Oragenics to Present at Sidoti’s Micro-Cap Virtual Investor Conference May 20-21
19/05/2026 -
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
19/05/2026
Pages